Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

This study is currently recruiting participants.
Verified February 2014 by Pfizer
Sponsor:
Collaborator:
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT01227564
First received: October 22, 2010
Last updated: February 20, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)